In VivoWith the addition of weight loss and obesity indications and more patient-friendly dosing regimens beginning at the start of the current decade, glucagon-like-peptide-1 (GLP-1) receptor agonists have
ScripThe BIOSECURE Act, when enacted, could leave some US pharma firms with pretty big shoes to fill given that it will strip the supply pool of WuXi AppTec Inc. , WuXi Biologics , Complete Genomics Inc
Generics BulletinThe active pharmaceutical ingredients (API) segment is witnessing a gradual restructuring with an increasing number of large Indian companies expanding their presence via new facilities or stake acqui
ScripThe active pharmaceutical ingredients (API) segment is witnessing a gradual restructuring with an increasing number of large Indian companies expanding their presence via new facilities or stake acqui